|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 144.1 USD | +3.59% |
|
+9.30% | -20.09% |
| Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
| Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
On March 2, 2022, Jane Huang, M.D., Chief Medical Officer, Hematology of BeiGene, Ltd., provided notice of her resignation from the Company effective April 3, 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.09% | 15.06B | |
| -1.51% | 104B | |
| +3.22% | 97.42B | |
| +1.22% | 22.2B | |
| -16.53% | 21.23B | |
| -8.84% | 18.33B | |
| -42.33% | 16.35B | |
| +5.47% | 13.98B | |
| +28.85% | 11.66B | |
| -24.93% | 8.22B |
BEIGENE, LTD. 
